State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma

The most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of thes...

Full description

Bibliographic Details
Main Authors: Anna Castaldo, Davide Raffaele De Lucia, Giuseppe Pontillo, Marco Gatti, Sirio Cocozza, Lorenzo Ugga, Renato Cuocolo
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/7/1194
id doaj-3b68f61953b543f39ed07f30b64b9e90
record_format Article
spelling doaj-3b68f61953b543f39ed07f30b64b9e902021-07-23T13:37:08ZengMDPI AGDiagnostics2075-44182021-06-01111194119410.3390/diagnostics11071194State of the Art in Artificial Intelligence and Radiomics in Hepatocellular CarcinomaAnna Castaldo0Davide Raffaele De Lucia1Giuseppe Pontillo2Marco Gatti3Sirio Cocozza4Lorenzo Ugga5Renato Cuocolo6Department of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyRadiology Unit, Department of Surgical Sciences, University of Turin, 10124 Turin, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyThe most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of these patients. While imaging characteristics of HCC are well-defined in the diagnostic phase, challenging cases still occur, and current prognostic and predictive models are limited in their accuracy. Radiomics and machine learning (ML) offer new tools to address these issues and may lead to scientific breakthroughs with the potential to impact clinical practice and improve patient outcomes. In this review, we will present an overview of these technologies in the setting of HCC imaging across different modalities and a range of applications. These include lesion segmentation, diagnosis, prognostic modeling and prediction of treatment response. Finally, limitations preventing clinical application of radiomics and ML at the present time are discussed, together with necessary future developments to bring the field forward and outside of a purely academic endeavor.https://www.mdpi.com/2075-4418/11/7/1194hepatocellular carcinomaimagingradiomicsmachine learningdeep learning
collection DOAJ
language English
format Article
sources DOAJ
author Anna Castaldo
Davide Raffaele De Lucia
Giuseppe Pontillo
Marco Gatti
Sirio Cocozza
Lorenzo Ugga
Renato Cuocolo
spellingShingle Anna Castaldo
Davide Raffaele De Lucia
Giuseppe Pontillo
Marco Gatti
Sirio Cocozza
Lorenzo Ugga
Renato Cuocolo
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
Diagnostics
hepatocellular carcinoma
imaging
radiomics
machine learning
deep learning
author_facet Anna Castaldo
Davide Raffaele De Lucia
Giuseppe Pontillo
Marco Gatti
Sirio Cocozza
Lorenzo Ugga
Renato Cuocolo
author_sort Anna Castaldo
title State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
title_short State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
title_full State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
title_fullStr State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
title_full_unstemmed State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
title_sort state of the art in artificial intelligence and radiomics in hepatocellular carcinoma
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2021-06-01
description The most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of these patients. While imaging characteristics of HCC are well-defined in the diagnostic phase, challenging cases still occur, and current prognostic and predictive models are limited in their accuracy. Radiomics and machine learning (ML) offer new tools to address these issues and may lead to scientific breakthroughs with the potential to impact clinical practice and improve patient outcomes. In this review, we will present an overview of these technologies in the setting of HCC imaging across different modalities and a range of applications. These include lesion segmentation, diagnosis, prognostic modeling and prediction of treatment response. Finally, limitations preventing clinical application of radiomics and ML at the present time are discussed, together with necessary future developments to bring the field forward and outside of a purely academic endeavor.
topic hepatocellular carcinoma
imaging
radiomics
machine learning
deep learning
url https://www.mdpi.com/2075-4418/11/7/1194
work_keys_str_mv AT annacastaldo stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
AT davideraffaeledelucia stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
AT giuseppepontillo stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
AT marcogatti stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
AT siriococozza stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
AT lorenzougga stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
AT renatocuocolo stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma
_version_ 1721288765168680960